[{"status": "Terminated", "city": "East Bank Demerara", "state": "", "country": "Guyana", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69206", "recalling_firm": "New Gpc Inc.", "address_1": "Lot A1, Farm", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D0034-2015", "product_description": "Whitfield's OINTMENT B.P., Net Contents: 15g.  Manufactured by: NEW GPC INC. A1 Farm, EBD.  Country of Origin Guyana.", "product_quantity": "4320 units", "reason_for_recall": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A.", "recall_initiation_date": "20140807", "center_classification_date": "20141017", "termination_date": "20180604", "report_date": "20141029", "code_info": "Batch Numbers: 202504, 310455", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93500", "recalling_firm": "AnazaoHealth Corporation", "address_1": "7465 W Sunset Rd Ste 1200", "address_2": "", "postal_code": "89113-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0204-2024", "product_description": "Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Vegas, NV, NDC 72682-8721-3.", "product_quantity": "3,363 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20231122", "center_classification_date": "20231226", "termination_date": "20250929", "report_date": "20240103", "code_info": "Lots: 508029, Exp: 12/14/23; 513191, Exp: 12/22/23; 524670, Exp: 01/12/24; 526254, Exp: 01/13/24; 530738, Exp: 01/19/23; 533570, Exp: 01/25/24; 538736, Exp: 02/03/24; 543220, Exp:02/16/24; 543508, Exp: 02/17/24; 545675, Exp: 02/22/24", "more_code_info": ""}, {"status": "Terminated", "city": "Henderson", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80343", "recalling_firm": "Gaia Ethnobotanical LLC", "address_1": "2752 Botticelli Dr", "address_2": "", "postal_code": "89052-3107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide.", "recall_number": "D-0996-2018", "product_description": "Gaia Kratom (mitragyna speciosa) powder, Green Dragon, 1oz, 250g, 1kg packages, Gaia Ethnobotanical.com", "product_quantity": "unknown", "reason_for_recall": "Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination", "recall_initiation_date": "20180620", "center_classification_date": "20180726", "termination_date": "20220126", "report_date": "20180718", "code_info": "Lot # 0102031800", "more_code_info": ""}, {"status": "Terminated", "city": "Hicksville", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94277", "recalling_firm": "Apothecus Pharmaceutical Corp.", "address_1": "485 S Broadway Ste 27", "address_2": "N/A", "postal_code": "11801-5071", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0427-2024", "product_description": "VCF Vaginal Contraceptive Film (nonoxynol-9, 28%), package in a carton with 9 single films, Distributed By: Apothecus Pharmaceutical Corp, Ronkonkoma, NY 11779, NDC 52925-112-01", "product_quantity": "17,280 paper cartons", "reason_for_recall": "cGMP Diviations", "recall_initiation_date": "20240321", "center_classification_date": "20240328", "termination_date": "20240909", "report_date": "20240403", "code_info": "Lot # 1G008A/1G00804722, Exp 07/31/25", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0228-2020", "product_description": "S-HYDROCHLORIC ACID 2MG/ML INJ SOLN, 50 ML glass vial, Red Mountain Compounding RX", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #:  S06092019DH@03, Exp 9/9/19; S06162019DH@17, Exp 9/16/19"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078378"], "brand_name": ["REVONTO"], "generic_name": ["DANTROLENE SODIUM"], "manufacturer_name": ["USWM, LLC"], "product_ndc": ["78670-003"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["DANTROLENE SODIUM"], "rxcui": ["856696", "1012465"], "spl_id": ["e2a8cdae-f253-4b7a-b9ab-c66506106aef"], "spl_set_id": ["f1650487-32bd-4017-b9c2-b38829a531af"], "package_ndc": ["78670-003-67"], "is_original_packager": [true], "unii": ["287M0347EV"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1081-2022", "product_description": "Revonto (dantrolene sodium for injection), 20 mg/vial, 6-count box, Rx only, MFG: US WorldMeds, Inc.,  NDC 78670-003-67", "product_quantity": "49 cartons/6 vials each", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0712-2021", "product_description": "MORPHINE-HYDROMORPHONE-BUPIVACAINE PF 13MG-19MG-2MG/ML INJECTABLE 21 mL syringe, Rx only, Med Shop 470 E. Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09292020@64, BUD 10/28/2020"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1259-2015", "product_description": "Lisinopril Tablets USP, 20 mg Tablets,  Packaged in A) 100 Count Bottles (NDC: 64679-941-01), B) 500 Count Bottles (NDC: 64679-941-05), and C) 1000 Count Bottles (NDC: 64679-941-06), Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.", "product_quantity": "A) 121,608 Bottles, B) 11,000 Bottles, and C) 152,773 Bottles.", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "A) Lot #: DM11334, Expiry: 4/30/2015; Lot #: DM11551, Expiry: 6/30/2015; Lot #: DM11995, Expiry: 7/31/2015; Lot #: DM12007, Expiry: 7/31/2015; Lot #: DM12480, Expiry: 8/31/2015; Lot #: DN10255, Expiry: 12/31/2015; Lot #: DN10410, Expiry: 1/31/2016; Lot #: DN10897, Expiry: 2/29/2016.  B) Lot #: DM11556, Expiry: 6/30/2015; Lot #: DM11567, Expiry: 6/30/2015; Lot #: DM12008, Expiry: 7/31/2015; Lot #: DM12482, Expiry: 8/31/2015.  C) Lot #: DM11119, Expiry: 4/30/2015; Lot #: DM11131, Expiry: 4/30/2015; Lot #: DM11132, Expiry: 4/30/2015; Lot #: DM11144, Expiry: 4/30/2015; Lot #: DM11145, Expiry: 4/30/2015; Lot #: DM11161, Expiry: 4/30/2015; Lot #: DM11162, Expiry: 4/30/2015; Lot #: DM11181, Expiry: 4/30/2015; Lot #: DM11182, Expiry: 4/30/2015; Lot #: DM11185, Expiry: 4/30/2015; Lot #: DM11335, Expiry: 5/31/2015; Lot #: DM11352, Expiry: 5/31/2015; Lot #: DM11357, Expiry: 5/31/2015; Lot #: DM11358, Expiry: 5/31/2015: Lot #: DM11366, Expiry: 5/31/2015; Lot #: DM11367, Expiry: 5/31/2015: Lot #: DM11390, Expiry: 5/31/2015; Lot #: DM11396, Expiry: 5/31/2015; Lot #: DM11397, Expiry: 5/31/2015; Lot #: DM11407, Expiry: 5/31/2015; Lot #: DM11408, Expiry: 5/31/2015; Lot #: DM11410, Expiry: 5/31/2015; Lot #: DM11427, Expiry: 5/31/2015; Lot #: DM11428, Expiry: 5/31/2015; Lot #: DM11443, Expiry: 5/31/2015; Lot #: DM11983, Expiry: 7/31/2015; Lot #: DM11984, Expiry: 7/31/2015; Lot #: DM11985, Expiry: 7/31/2015; Lot #: DM11986, Expiry: 7/31/2015; Lot #: DM11996, Expiry: 7/31/2015; Lot #: DM12005, Expiry: 7/31/2015; Lot #: DM12006, Expiry: 7/31/2015; Lot #: DM12045, Expiry: 7/31/2015; Lot #: DM12046, Expiry: 7/31/2015; Lot #: DM12056, Expiry: 7/31/2015; Lot #: DM12057, Expiry: 7/31/2015; Lot #: DM12061, Expiry: 7/31/2015; Lot #: DM12065, Expiry: 7/31/2015; Lot #: DM12079, Expiry: 7/31/2015; Lot #: DM12080, Expiry: 7/31/2015; Lot #: DM12453, Expiry: 8/31/2015; Lot #: DM12455, Expiry: 8/31/2015; Lot #: DM12466, Expiry: 8/31/2015; Lot #: DM12467, Expiry: 8/31/2015; Lot #: DM12478, Expiry: 8/31/2015; Lot #: DM12479, Expiry: 8/31/2015; Lot #: DM13072, Expiry: 10/31/2015; Lot #: DM13093, Expiry: 10/31/2015; Lot #: DM13098, Expiry: 10/31/2015; Lot #: DM13099, Expiry: 10/31/2015; Lot #: DM13220, Expiry: 10/31/2015; Lot #: DM13221, Expiry: 10/31/2015; Lot #: DM13362, Expiry: 11/30/2015; Lot #: DM13363, Expiry: 11/30/2015; Lot #: DM13386, Expiry: 11/30/2015; Lot #: DM13392, Expiry: 11/30/2015; Lot #: DM13414, Expiry: 11/30/2015: Lot #: DM13441, Expiry: 11/30/2015; Lot #: DM13454, Expiry: 11/30/2015; Lot #: DN10253, Expiry: 12/31/2015; Lot #: DN10254, Expiry: 12/31/2015; Lot #: DN10261, Expiry: 12/31/2015; Lot #: DN10262, Expiry: 12/31/2015; Lot #: DN10282, Expiry: 12/31/2015; Lot #: DN10283, Expiry: 12/31/2015; Lot #: DN10284, Expiry: 12/31/2015; Lot #: DN10293, Expiry: 12/31/2015; Lot #: DN10294, Expiry: 12/31/2015; Lot #: DN10295, Expiry: 12/31/2015; Lot #: DN10309, Expiry: 12/31/2015; Lot #: DN10411, Expiry: 1/31/2016; Lot #: DN10455, Expiry: 1/31/2016; Lot #: DN10464, Expiry: 1/31/2016; Lot #: DN10485, Expiry: 1/31/2016; Lot #: DN10497, Expiry: 1/31/2016; Lot #: DN10505, Expiry: 1/31/2016; Lot #: DN10506, Expiry: 1/31/2016; Lot #: DN10524, Expiry: 1/31/2016; Lot #: DN10534, Expiry: 1/31/2016; Lot #: DN10535, Expiry: 1/31/2016; Lot #: DN10554, Expiry: 1/31/2016; Lot #: DN10555, Expiry: 1/31/2016; Lot #: DN10909, Expiry: 2/29/2016; Lot #: DN10910, Expiry: 2/29/2016; Lot #: DN10923, Expiry: 2/29/2016; Lot #: DN10928, Expiry: 3/31/2016; Lot #: DN10929, Expiry: 3/31/2016; Lot #: DN10954, Expiry: 3/31/2016; Lot #: DN10970, Expiry: 3/31/2016; Lot #: DN10971, Expiry: 3/31/2016; Lot #: DN10986, Expiry: 3/31/2016; Lot #: DN10987, Expiry: 3/31/2016."}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0211-2019", "product_description": "Water Sterile for Injection 250 mL IV Pharm D Solutions, Houston, Texas --- NDC 69699-1407-25", "product_quantity": "12 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 05222018:12 Discard by: 10/21/2018"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: PARICALCITOL, Capsule, 1 mcg may have potentially been mislabeled as one of the following drugs:  ASCORBIC ACID, Tablet, 500 mg, NDC 60258014101, Pedigree: AD23082_19, EXP: 5/6/2014;  CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: W002666, EXP: 6/5/2014.", "address_2": "", "product_quantity": "60 Capsules", "code_info": "PARICALCITOL, Capsule, 1 mcg has the following codes:   Pedigree: AD23082_22, EXP: 5/6/2014;  Pedigree: W002667, EXP: 6/5/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "PARICALCITOL, Capsule, 1 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00074431730.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-809-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "South Richmond Hill", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85992", "recalling_firm": "MasterPharm LLC", "address_1": "11502 Liberty Ave Fl 2", "address_2": "N/A", "postal_code": "11419-1902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-1441-2020", "product_description": "Testosterone/Anastrozole Pellet 100/6 mg, 100 pellets per bottle, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419  (866) 630-5600", "product_quantity": "339 pellets", "reason_for_recall": "Lack of Processing Controls (lack of assurance of conformity to specifications).", "recall_initiation_date": "20200702", "center_classification_date": "20200729", "termination_date": "20240223", "report_date": "20200805", "code_info": "02-10-2020:06@32, BUD 8/2/2020"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0252-2024", "product_description": "Old Spice, SWEAT DEFENSE  ULTIMATE CAPTAIN, Aluminum Chlorohydrate 23.5%, Anti-Perspirant, Topical spray can 3.8 OZ (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-385-10, UPC 0 37000 74947 9", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0871-2021", "product_description": "Kali Sulphuricum 3X, 960ml 20% Alcohol, WHP Homeopathic Medicine, For Manufacturing Use Only. Manufactured by Washington Homeopathic Products 260JR hawvermale Way Berkeley Springs WV 25411.", "product_quantity": "12/960 mL bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29475, Exp 8/17/2026"}, {"status": "Completed", "city": "Irving", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91272", "recalling_firm": "NCH Life Sciences LLC", "address_1": "2730 Carl Rd", "address_2": "", "postal_code": "75062-6405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in United States and Canada.", "recall_number": "D-0092-2023", "product_description": "Alcohol Antiseptic 80% Topical Solution Hand Sanitizer, Non-Sterile Solution, packaged as a a) 2.5 gallon bottle (9,464 ml), NDC 55533-524-02, and b) 55 gallon bottle (208,198 ml), NDC 55533-524-03, Manufactured for: Multi-Mist Products A Division of NCH Corporation 1618 Northgate, Irving, Texas 75062", "product_quantity": "10,930 gallons", "reason_for_recall": "CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.", "recall_initiation_date": "20221209", "center_classification_date": "20221228", "report_date": "20230104", "code_info": "Lots: 12032504, 12014282, 12013501, 12104039, 12013505, 12032523, 12013510, 12014804, 12015401, and 12014113", "more_code_info": ""}, {"status": "Ongoing", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203088"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE HYDROCHLORIDE"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "product_ndc": ["51991-746", "51991-747", "51991-748", "51991-750"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["32327581-bdab-41ac-9adc-bf208e1c4e42"], "spl_set_id": ["caef6f50-1571-4ec7-8f8c-42b924d323ee"], "package_ndc": ["51991-746-06", "51991-746-90", "51991-746-05", "51991-747-33", "51991-747-90", "51991-747-10", "51991-748-33", "51991-748-90", "51991-748-10", "51991-750-33", "51991-750-90", "51991-750-05", "51991-750-10"], "is_original_packager": [true], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "96707", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Nationwide.", "recall_number": "D-0387-2025", "product_description": "Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, Manufactured by Towa Pharmaceutical Europe, S.L., Distributed by Breckenridge Pharmaceutical, Inc. Berkeley Heights, NJ 07922, NDC# 51991-748-10", "product_quantity": "16,473 bottles", "reason_for_recall": "CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.", "recall_initiation_date": "20250414", "center_classification_date": "20250422", "report_date": "20250430", "code_info": "Lot #  240987C, exp. date 04/2027 241014C, exp. date 04/2027"}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0354-2022", "product_description": "amazon basic+care, Allergy Fexofenadine Hydrochloride Tablets, 60 mg/Antihistamine,  12HR, 100 count bottle, Made in the Czech Republic, Distributed by: Amazon.com services LLC 410 Terry Avenue N., Seattle WA 98109, NDC 72288-425-78 UPC 3 70030 14536 2", "product_quantity": "38,352 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot # 1AR0558, Exp 7/31/2022"}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C236 BUD: 11/13/2018", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 12.5mg pellet, 1 count (NDC 69761-012-01), 6 count (NDC 69761-012-06), 12 count (NDC 69761-012-12), and 30 count (NDC 69761-012-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0226-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90127", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to FL, SC and VA", "recall_number": "D-0886-2022", "product_description": "Losartan HCTZ 100/25 mg, 90 count bottles  NDC# 70518-2578-00 Repackaged NDC  Original NDC # 68180-0217-09", "product_quantity": "26/90 count bottles = 2,340 tablets", "reason_for_recall": "CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.", "recall_initiation_date": "20220502", "center_classification_date": "20220520", "termination_date": "20220902", "report_date": "20220601", "code_info": "Lot #   B1329507-082921, exp. date 08/31/2022  B1348363-091421, exp. date 09/30/2022  B1387286-101021, exp. date 10/31/2022  B1390974-101221, exp. date 10/31/2022  B1426010-110521, exp. date 11/30/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87548", "recalling_firm": "Asclemed USA Inc. dba Enovachem Pharmaceuticals", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "N/A", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to three physicians in the following states: CA, LA (Enovachem). DocRx distributed recalled product to one Distributor located in AL.", "recall_number": "D-0330-2021", "product_description": "Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC: 69306-004-21, Relabeled by: Enovachem Pharmaceuticals 379 Van Ness Ave. Suite 1403-1406, Torrance, CA 90501, Manufactured by: Jubilant Cadista Pharmaceuticals Inc. Source NDC: 59746-001-03, DocRx, Mobile, AL 36608", "product_quantity": "N/A", "reason_for_recall": "Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.", "recall_initiation_date": "20210319", "center_classification_date": "20210412", "report_date": "20210421", "code_info": "Lot #: 20K0043P, Exp. 8/31/2022; 20L0026P, Exp. 9/30/2022"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83669", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0201-2020", "product_description": "S-ATROPINE 0.01% OPHTHALMIC SOLUTION, packaged in a) 10ml and b) 50 ml dropper bottle, Rx only, Red Mountain Compounding RX.", "product_quantity": "6x10 ml,  1x50 ml dropper bottle", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190812", "center_classification_date": "20191105", "termination_date": "20230413", "report_date": "20191113", "code_info": "Lot #: a) S06112019DH@22, Exp 9/11/19; S06202019DT@10, Exp 9/20/19;  S07312019DH@07, Exp 10/31/19;   b) S07302019DH@07, Exp 10/30/19"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0080-2016", "product_description": "ESTRADIOL, Pellet, 18 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "1 pellet", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t07312014@14"}, {"status": "Terminated", "city": "Melrose Park", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204223"], "brand_name": ["MORPHINE SULFATE"], "generic_name": ["MORPHINE SULFATE"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "product_ndc": ["63323-451", "63323-452", "63323-454", "63323-455", "63323-458"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["MORPHINE SULFATE"], "rxcui": ["1731993", "1732006", "1732011", "1732136", "2003714"], "spl_id": ["dbf870e7-7bfe-48f0-ba6a-9cc476dfe5cc"], "spl_set_id": ["582f42e5-444e-4246-af8c-e7e28097c69a"], "package_ndc": ["63323-452-00", "63323-452-01", "63323-454-00", "63323-454-01", "63323-455-00", "63323-455-01", "63323-458-00", "63323-458-01", "63323-451-00", "63323-451-01"], "is_original_packager": [true], "upc": ["0363323454005", "0363323451004"], "unii": ["X3P646A2J0"]}, "product_type": "Drugs", "event_id": "88698", "recalling_firm": "Fresenius Kabi USA LLC", "address_1": "2020 N Ruby St", "address_2": "N/A", "postal_code": "60160-1112", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0856-2021", "product_description": "Morphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047, NDC 63323-452-01.  25 vials per tray packaged 18 trays per shipper", "product_quantity": "963000 vials", "reason_for_recall": "Defective container: Cracked vials leading to lack of sterility assurance", "recall_initiation_date": "20210917", "center_classification_date": "20210927", "termination_date": "20230620", "report_date": "20211006", "code_info": "Lot #  6023731, 6023732, Exp 03/2023; 6024172, 6024260, Exp 06/2023"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "87 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03092015@20, 6/7/2015; 03202015@72, 6/18/2015; 04132015@9, 6/12/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 30 mg/ml + Clonidine 250 mcg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1595-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0966-2019", "product_description": "Dr. King's Natural Medicine Regional Allergies Canadian Prairies, 59 mL (liquid/liquide), DIN-HM 80074815 UPC 357955181729", "product_quantity": "710 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 021517L Exp. 02/20"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80646", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "N/A", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 3 medical facilities in Florida.", "recall_number": "D-1021-2018", "product_description": "Valsartan/HCTZ 320mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701", "product_quantity": "3 HDPE 90-count bottles (270 tablets)", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180717", "center_classification_date": "20180731", "termination_date": "20181017", "report_date": "20180808", "code_info": "Lot # B0383153-122917; Exp. 12/18"}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078215"], "brand_name": ["SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE"], "generic_name": ["SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9570"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["SODIUM FERRIC GLUCONATE COMPLEX"], "rxcui": ["242761"], "spl_id": ["7a57fb1e-f803-4f81-a643-6fc18d8371ff"], "spl_set_id": ["218d1b8d-b24f-4f77-b588-97c7dd1c2eec"], "package_ndc": ["0143-9570-01", "0143-9570-10"], "is_original_packager": [true], "nui": ["M0011718", "N0000177913"], "pharm_class_cs": ["Iron [CS]"], "pharm_class_epc": ["Parenteral Iron Replacement [EPC]"], "unii": ["CC9149U2QX"]}, "product_type": "Drugs", "event_id": "75784", "recalling_firm": "West-Ward Pharmaceuticals Corp.", "address_1": "401 Industrial Way West", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US nationwide", "recall_number": "D-0172-2017", "product_description": "SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION, 62.5mg elemental iron/5mL, 10 (5mL vials) per shelf pack, Rx only,  Mfd: Hikma Farmaceutica (Portugal,) SA   Distributed by: Westward Eatowntown NJ  07724 USA, Shelf pack NDC 0143-9570-10, Unit dose NDC 0143-9570-01", "product_quantity": "5,142 Shelf-packs", "reason_for_recall": "Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.", "recall_initiation_date": "20161117", "center_classification_date": "20161208", "termination_date": "20180419", "report_date": "20161214", "code_info": "Lot #: 152032.1, Exp. Date. 2/2017"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0155-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 1MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "50 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:  T1008192021:69 BUD: 02/15/2022; T1006142021:66 BUD: 12/11/2021; T1009092021:76 BUD: 03/08/2022; T1005142021:82 BUD: 11/10/2021; T1009212021:33 BUD: 03/20/2022; T1006012021:01 BUD: 11/28/2021", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "72 vials", "code_info": "Lot # 01-20-2017@74, Exp 4/20/2017; t02-01-2017@123, Exp 5/3/2017; t02-03-2017@47, Exp 5/7/2017; t02-07-2017@70, Exp 5/10/2017; t02-13-2017@100,  Exp 5/15/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HCG *10ML* MDV 500U/ML INJ, Injection, 500u/mL, Rx only, 10 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0720-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Murray", "state": "UT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "71989", "recalling_firm": "Novacare, LLC", "address_1": "312 W 6100 S", "address_2": "N/A", "postal_code": "84107-6990", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0962-2016", "product_description": "The People's Chemist Thermo FX Barely Legal Thermogenic Aid, packaged in 90 capsule containers.  Manufactured by TPC, LLC, www.thepeopleschemist.com.", "product_quantity": "N/A", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.", "recall_initiation_date": "20150824", "center_classification_date": "20160606", "termination_date": "20170830", "report_date": "20160615", "code_info": "UPC 793573902665"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0151-2016", "product_description": "TRIMIX, injectable Solution, 30MG/2MG/20MCG, syringe size: 10mL, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "10 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t12102014@2, t11212014@14, t11102014@22, t11072014@10, t10102014@20, t08072014@37, t06222015@13, t06192015@27, t06112015@23, t04142015@9, t02272015@26."}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "62511", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distribution was nationwide, including Puerto Rico.  There was no foreign, military, or government distribution.", "recall_number": "D-082-2013", "product_description": "Thyro-Tab 0.137 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "3,774,541 tablets", "reason_for_recall": "cGMP Deviations; does not meet in process specification requirements", "recall_initiation_date": "20120709", "center_classification_date": "20121203", "termination_date": "20131114", "report_date": "20121212", "code_info": "Lot #HA27911 and #HA12511"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66593", "recalling_firm": "Amedra Pharmaceuticals LLC", "address_1": "2 Walnut Grove Dr", "address_2": "Suite 190", "postal_code": "19044-2219", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-385-2014", "product_description": "Dexedrine\u00bf (Dextroamphetamine Sulfate) Spansules\u00bf Sustained Release Capsules 15mg, 90 count bottle, Rx only, Manufactured by Catalent Pharma Solutions Winchester, KY 40391 for Amedra Pharmaceuticals, LLC Middlesex, NJ 08846, NDC 52054-514-09", "product_quantity": "10,992 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.", "recall_initiation_date": "20131007", "center_classification_date": "20131223", "termination_date": "20141007", "report_date": "20140101", "code_info": "Lot#  243459; Exp. 01/14", "more_code_info": ""}, {"status": "Terminated", "city": "Northfield", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78575", "recalling_firm": "Medline Industries Inc", "address_1": "Three Lakes Drive", "address_2": "", "postal_code": "60093", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA, Puerto Rico, China, Chile, Guam, Honduras, India, Israel, Malaysia, Mexico, Turkey", "recall_number": "D-0257-2018", "product_description": "Medline Newborn Kit. Packaged for Medline Industries, Inc., Northfield, IL 60093", "product_quantity": "288 cases", "reason_for_recall": "Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.", "recall_initiation_date": "20170921", "center_classification_date": "20180204", "termination_date": "20230828", "report_date": "20180207", "code_info": "Pack Number: DYKL1133; Lots: 17IA0348;  17GA0975;  17IA0348", "more_code_info": ""}, {"status": "Ongoing", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210742"], "brand_name": ["CHLORTHALIDONE"], "generic_name": ["CHLORTHALIDONE"], "manufacturer_name": ["AvPAK"], "product_ndc": ["50268-167"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORTHALIDONE"], "rxcui": ["197499"], "spl_id": ["df21e622-654c-2eab-e053-2995a90a5f1c"], "spl_set_id": ["972b801e-c4f2-4bd6-e053-2a95a90a53bb"], "package_ndc": ["50268-167-11", "50268-167-15"], "original_packager_product_ndc": ["43598-719"], "nui": ["N0000175359", "N0000175420"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide-like Diuretic [EPC]"], "unii": ["Q0MQD1073Q"]}, "product_type": "Drugs", "event_id": "96866", "recalling_firm": "AvKARE", "address_1": "615 N 1st St", "address_2": "", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0461-2025", "product_description": "Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-167-15", "product_quantity": "962 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20250509", "center_classification_date": "20250609", "report_date": "20250618", "code_info": "Lot # 47947, Exp 05/31/2026", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: THYROID, Tablet, 60 mg may have potentially been mislabeled as the following drug:  THYROID, Tablet, 30 mg, NDC 00456045801, Pedigree: W002847, EXP: 6/7/2014.", "address_2": "", "product_quantity": "", "code_info": "THYROID, Tablet, 60 mg has the following codes:   Pedigree: W002848, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "THYROID, Tablet, 60 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00456045901.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-914-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lumberton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "83210", "recalling_firm": "AAA Pharmaceutical, Inc.", "address_1": "681 Main St", "address_2": "N/A", "postal_code": "08048-5013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "KS", "recall_number": "D-1585-2019", "product_description": "Smart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500 count UPC 8-83967-38786-1 bottles, Distributed by: Kmart Corporation Hoffman Estates, IL 60179", "product_quantity": "a) 288 bottles b) 48 bottles", "reason_for_recall": "Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.", "recall_initiation_date": "20190625", "center_classification_date": "20190802", "termination_date": "20201216", "report_date": "20190814", "code_info": "a) P136370, exp 9/2022  b) P136366, exp 9/2022"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1608-2020", "product_description": "WP Thyroid, Westhroid Pure, 3/4 Grain (48.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-5650-2 ; b) 30 Tablets, NDC  64727-5650-4; c) 60 Tablets, NDC 64727-5650-5; d) 90 Tablets, NDC 64727-5650-6; e) 100 Tablets, NDC 64727-5650-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0460-2021", "product_description": "PRAVACHOL 40MG 90; NDC/UPC 3519410; RX; TABLETS", "product_quantity": "3 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "ABA4203A1"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-051-2014", "product_description": "B-Complex 206 mg/ml 30ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-699-2015", "product_description": "Gemfibrozil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82021", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0491-2019", "product_description": "Diltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; NDC 68682-521-01.", "product_quantity": "23,884 bottles", "reason_for_recall": "Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.", "recall_initiation_date": "20190130", "center_classification_date": "20190214", "termination_date": "20200708", "report_date": "20190220", "code_info": "Lots: 18J035P, 18K094P, 18K093P, Exp 09/2020"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0043-2022", "product_description": "TEST CYP 200MG/ML IN SESAME OIL MDV, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0785-2019", "product_description": "Dr. King's SafeCare Rx Fear & Phobia, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955179023,NDC 57955-1791-2", "product_quantity": "552 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 072015E Exp. 07/18; 032216G Exp. 03/19; 102816E Exp. 10/19"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200909"], "brand_name": ["EZETIMIBE AND SIMVASTATIN"], "generic_name": ["EZETIMIBE AND SIMVASTATIN"], "manufacturer_name": ["Golden State Medical Supply"], "product_ndc": ["51407-190", "51407-191", "51407-192", "51407-193"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["EZETIMIBE", "SIMVASTATIN"], "rxcui": ["476345", "476349", "476350", "476351"], "spl_id": ["0c7b8b84-3a6b-7cb1-e063-6294a90a42a4"], "spl_set_id": ["88cd0e7b-e8dc-6125-e053-2a95a90aaa27"], "package_ndc": ["51407-190-30", "51407-190-90", "51407-190-10", "51407-191-30", "51407-191-90", "51407-191-10", "51407-192-30", "51407-192-90", "51407-192-05", "51407-192-10", "51407-193-30", "51407-193-90", "51407-193-05"], "original_packager_product_ndc": ["43598-742", "43598-744", "43598-743", "43598-745"], "nui": ["N0000175589", "N0000000121", "N0000008553", "N0000175911"], "pharm_class_epc": ["HMG-CoA Reductase Inhibitor [EPC]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "pharm_class_moa": ["Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "unii": ["AGG2FN16EV", "EOR26LQQ24"]}, "product_type": "Drugs", "event_id": "88866", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "N/A", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to two distributors located in AZ and MO", "recall_number": "D-0227-2022", "product_description": "Ezetimibe and Simvastatin Tablets, 10 mg/40mg, a) 90 Tablets, b) 500 tablets, Rx only, Manufactured by Dr. Reddy's Laboratories LA LLC Shreveport, LA 71106 USA, Packaged by GSMS, Incorporated Camarillo, CA 93012 USA; NDC: a) 51407-192-90, b) 51407-192-05", "product_quantity": "a) 101 b) 145 bottles", "reason_for_recall": "Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle", "recall_initiation_date": "20211014", "center_classification_date": "20211109", "termination_date": "20221110", "report_date": "20211117", "code_info": "a) Lot: GS038610, Exp: 01/2023; b) GS038891, Exp: 1/2023", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA022458"], "brand_name": ["ELELYSO"], "generic_name": ["TALIGLUCERASE ALFA"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "product_ndc": ["0069-0106"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TALIGLUCERASE ALFA"], "rxcui": ["1292879", "1292881"], "spl_id": ["9e5fbf74-2937-46bd-bfaa-b8aab9386998"], "spl_set_id": ["fa3cbd5d-677c-4b19-9032-d9182cb69a83"], "package_ndc": ["0069-0106-01"], "is_original_packager": [true], "nui": ["N0000175820", "M0009360"], "pharm_class_epc": ["Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]"], "pharm_class_cs": ["Glucosylceramidase [CS]"], "unii": ["0R4NLX88O4"]}, "product_type": "Drugs", "event_id": "85067", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States and Albania, Israel, Serbia, Macedonia, Afghanistan, Botswana/South Africa/Zimbabwe, India, Israel, Rwanda, Uruguay, Mongolia", "recall_number": "D-0995-2020", "product_description": "Elelyso (taliglucerase alfa) for injection, 200 units/vials,, Rx only, Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017.  NDC 0069-0106-01", "product_quantity": "24,714 vials", "reason_for_recall": "Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.", "recall_initiation_date": "20200227", "center_classification_date": "20200305", "termination_date": "20221228", "report_date": "20200311", "code_info": "Lot #:  X14209, Exp. Date 02/2020; AH4601, Exp. Date 03/2020; AH4603, X46389, X78365, AT2927, Exp. Date 04/2020; AH4602, Exp. Date 05/2020;  AL8590, Exp. Date 10/2020"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "3 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Alcohol4%/Bupivicaine0.5%  sol, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0417-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "82362", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "United States and Puerto Rico", "recall_number": "D-1073-2019", "product_description": "8.4% Sodium Bicarbonate Injection, USP 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL) 50 mL Single-dose fliptop vial, 25 vials per carton, Rx only Hospira, Inc. Lake Forest, IL 60045 USA ---- NDC 0409-6625-02", "product_quantity": "283,400 vials", "reason_for_recall": "Presence of Particulate Matter; glass particulates", "recall_initiation_date": "20190315", "center_classification_date": "20190329", "termination_date": "20210127", "report_date": "20190410", "code_info": "Lots: 79-238-EV Exp. 1 July 2019; 79-240-EV Exp. 1 July 2019; 80-088-EV Exp. 1 August 2019"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "80782", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-1186-2018", "product_description": "Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01", "product_quantity": "11,799 bottles of 100", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.", "recall_initiation_date": "20180807", "center_classification_date": "20180910", "termination_date": "20190814", "report_date": "20180919", "code_info": "Batch code # 3093163, expiration date 04/2019"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "260", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Fentanyl Citrate 2.5 mcg/mL & Bupivacaine 0.075% in 0.9% Sodium Chloride, 60 mL BD syringe, Rx Only,  Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC # 45183-0826-77", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1308-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Ocala", "address_1": "202 SW 17th St Suite C", "reason_for_recall": "Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.", "address_2": "", "product_quantity": "14 units", "code_info": "Rx # 29140, Exp 05/23/14", "center_classification_date": "20140724", "distribution_pattern": "Florida", "state": "FL", "product_description": "Vancomycin 1.25 gm/250 mL 0.9%NS,Trinity Care Solutions, 202-C SW 17th Street, Ocala, FL 34471-5138, For Parenteral Use Only, Rx # 29140, Discard After 05/23/14", "report_date": "20140730", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc dba Trinity Care Solutions", "recall_number": "D-1473-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "68497", "more_code_info": "", "recall_initiation_date": "20140515", "postal_code": "34471-8138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg may have potentially been mislabeled as the following drug:  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00904421713, Pedigree: AD32582_3, EXP: 5/9/2014.", "address_2": "", "product_quantity": "30 Tablets", "code_info": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg has the following codes:   Pedigree: AD32579_7, EXP: 5/9/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "BROMOCRIPTINE MESYLATE, Tablet, 2.5 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781532531.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1011-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "73295", "recalling_firm": "Virtus Pharmaceuticals, Llc", "address_1": "2649 Causeway Center Dr", "address_2": "N/A", "postal_code": "33619-6102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0801-2016", "product_description": "VP-CH-PNV PRENATAL/POSTNATAL Prescription Folic Acid-Containing Dietary Supplement, 30-count Softgel bottles, Rx, Manufactured for Vitrus Pharmaceuticals, LLC, Tampa, FL 33619, NDC 69543-224-30, UPC 369543224305", "product_quantity": "688 bottles ( 20,640 softgel capsules)", "reason_for_recall": "Defective Delivery System: Product may contain leaking capsules.", "recall_initiation_date": "20151217", "center_classification_date": "20160401", "termination_date": "20180816", "report_date": "20160413", "code_info": "Lot #21506132; Exp. 05/17", "more_code_info": ""}, {"status": "Terminated", "city": "Daytona Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80750", "recalling_firm": "Product Quest Manufacturing LLC", "address_1": "330 Carswell Ave", "address_2": "N/A", "postal_code": "32117-4416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0050-2019", "product_description": "QC Quality Choice, Saline Nasal Relief, Moisturizing Nasal Spray, Sodium Chloride 0.65%, packaged as a) 1.5 FL OZ (45 mL) bottle UPC 6 35515 98845 3; b) 3 FL OZ (89 mL) bottle UPC 6 35515 95042 9, Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376-0995.", "product_quantity": "172,800 bottles", "reason_for_recall": "CGMP Deviations: products manufactured under conditions that could impact its product quality.", "recall_initiation_date": "20180803", "center_classification_date": "20181016", "termination_date": "20210330", "report_date": "20181024", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Aventura", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81436", "recalling_firm": "Zero Xtreme USA", "address_1": "20533 Biscayne Blvd # 825", "address_2": "", "postal_code": "33180-1529", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the USA.", "recall_number": "D-0246-2019", "product_description": "Zero Xtreme Dietary Supplement 30-count capsules.  By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA", "product_quantity": "16 bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine", "recall_initiation_date": "20181015", "center_classification_date": "20181115", "termination_date": "20220118", "report_date": "20181121", "code_info": "Lot: 1220062085 Exp. 03/2020", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "82386", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Guam", "recall_number": "D-1071-2019", "product_description": "Clindamycin Injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vials, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC 47781-620-94", "product_quantity": "8,878 cartons (25 vials per carton)", "reason_for_recall": "Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point", "recall_initiation_date": "20190315", "center_classification_date": "20190329", "termination_date": "20220811", "report_date": "20190410", "code_info": "Lot #: T97496, Exp.04/2019, T97497, Exp.07/2019, W28564(exp 09/2019), W31812, Exp. 10/2019."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64056", "recalling_firm": "Watson Pharmaceuticals", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-145-2013", "product_description": "Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.", "product_quantity": "3,040 bottles", "reason_for_recall": "Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).", "recall_initiation_date": "20121218", "center_classification_date": "20130204", "termination_date": "20140730", "report_date": "20130213", "code_info": "Lot #: 512146A, Exp 01/31/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Latham", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70807", "recalling_firm": "Fallon Wellness Pharmacy, L.L.C.", "address_1": "1057 Troy Schenectady Rd", "address_2": "N/A", "postal_code": "12110-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D-1067-2015", "product_description": "Methylcobalamin/B-Complex Rx 2.5/103 mg/mL Injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110", "product_quantity": "12 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150317", "center_classification_date": "20150512", "termination_date": "20180605", "report_date": "20150520", "code_info": "Lot#: 02112015@35, Exp 4/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0802-2022", "product_description": "AT-1, Papaverine 8mg/ml . Phentolamine 2mg/ml . Atropine 0.2mg/ml, Multi-Dose 10 ml vial,  Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0039-10", "product_quantity": "310 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: F41C28 BUD: 6/28/2022, F41B28 BUD: 6/28/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-201-2014", "product_description": "Medroxyprogesterone 150mg 1ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1131 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71104", "recalling_firm": "Wockhardt Usa Inc.", "address_1": "20 Waterview Blvd Ste 3", "address_2": "N/A", "postal_code": "07054-1271", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide including Puerto Rico.", "recall_number": "D-1243-2015", "product_description": "Amlodipine Besylate Tablets, 2.5 mg Tablets, Packaged in 90 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA.  NDC: 64679-421-01.", "product_quantity": "124,034 Bottles", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150422", "center_classification_date": "20150717", "termination_date": "20180509", "report_date": "20150729", "code_info": "Lot #: DM11774, Expiry: 6/30/2015; Lot #: DM13056, Expiry: 10/31/2015; Lot #: DM13117, Expiry: 10/31/2015; Lot #: DM13159, Expiry: 10/31/2015; Lot #: DM13186, Expiry: 10/31/2015; Lot #: DM13187, Expiry: 10/31/2015; Lot #: DM13188, Expiry: 10/31/2015; Lot #: DN10003, Expiry: 11/30/2015; Lot #: DN10045, Expiry: 11/30/2015; Lot #: DN10046, Expiry: 11/30/2015; Lot #: DN10389, Expiry: 1/31/2016; Lot #: DN10412, Expiry: 1/31/2016; Lot #: DN10604, Expiry: 1/31/2016."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-712-2015", "product_description": "Hydrochlorothiazide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "5500 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-024-2014", "product_description": "17-P 1ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "875 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0752-2019", "product_description": "Dr. King's SafeCare Rx Sluggish Mind Mind & Body, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955152026, NDC 57955-1521-2", "product_quantity": "101 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021616F Exp. 02/19; 111416A Exp. 11/19"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA210450"], "brand_name": ["ORILISSA"], "generic_name": ["ELAGOLIX"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-0038", "0074-0039"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ELAGOLIX SODIUM"], "rxcui": ["2049852", "2049858", "2049860", "2049862"], "spl_id": ["fe82adb5-4113-48ee-844a-dd3ccc4a3dbd"], "spl_set_id": ["a86757b3-09c5-fd3b-1223-244e94f50a66"], "package_ndc": ["0074-0038-28", "0074-0038-01", "0074-0038-07", "0074-0039-56", "0074-0039-01", "0074-0039-14"], "is_original_packager": [true], "unii": ["5948VUI423"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0403-2021", "product_description": "Orilissa elagolix tablets 150 mg per tablet equivalent to 155.2 mg elagolix sodium, 28 Tablets For 28 Days Rx only NDC 0074-0038-28  Each carton contains 28 tablets in 4 weekly blister pack, Each weekly blister pack contains 7 tablets of elagolix 150 mg AbbVie Inc. North Chicago, IL 60064", "product_quantity": "210 cartons", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1120778"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205006"], "brand_name": ["LACOSAMIDE"], "generic_name": ["LACOSAMIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc. USA"], "product_ndc": ["68462-678", "68462-679", "68462-680", "68462-681"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LACOSAMIDE"], "rxcui": ["809987", "809992", "809996", "810000"], "spl_id": ["a65056ce-b6e9-4bed-adbd-98052a2e705e"], "spl_set_id": ["df1d2e6a-6129-49c9-b2c1-0fdf73f38b9c"], "package_ndc": ["68462-678-30", "68462-678-60", "68462-678-10", "68462-679-30", "68462-679-60", "68462-679-10", "68462-680-30", "68462-680-60", "68462-680-10", "68462-681-30", "68462-681-60", "68462-681-10"], "is_original_packager": [true], "upc": ["0368462680605", "0368462681602"], "nui": ["N0000008486"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "unii": ["563KS2PQY5"]}, "product_type": "Drugs", "event_id": "96474", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide", "recall_number": "D-0343-2025", "product_description": "Lacosamide Tablets 150mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.NDC# 68462-680-60.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250313", "center_classification_date": "20250408", "report_date": "20250416", "code_info": "Lot #  17241125, exp. date Jun-26 17242202, exp. date  Nov-26 17242204, exp. date Dec-26"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0971-2023", "product_description": "vancomycin 750 mg/250 mL added to 0.9% Sodium Chloride, (3 mg/mL), IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6071-1", "product_quantity": "1927 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239990, Exp. 7/13/2023; 36-240839, Exp. 7/18/2023; 36-242706, Exp. 7/26/2023; 36-243952, Exp. 7/31/2023; 36-253889, Exp. 8/31/2023; 36-255691, Exp. 9/7/2023."}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078895"], "brand_name": ["CLONIDINE HYDROCHLORIDE"], "generic_name": ["CLONIDINE HYDROCHLORIDE"], "manufacturer_name": ["Unichem Pharmaceuticals (USA), Inc."], "product_ndc": ["29300-135", "29300-468", "29300-136", "29300-137"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CLONIDINE HYDROCHLORIDE"], "rxcui": ["884173", "884185", "884189"], "spl_id": ["5929c96f-9fa9-4399-84aa-28584da9966a"], "spl_set_id": ["21bfa28f-20df-43fd-bb80-b720d3b40696"], "package_ndc": ["29300-468-05", "29300-468-10", "29300-468-50", "29300-468-01", "29300-136-01", "29300-136-05", "29300-136-10", "29300-136-50", "29300-137-01", "29300-137-05", "29300-137-10", "29300-137-25", "29300-135-01", "29300-135-05", "29300-135-10", "29300-135-50"], "is_original_packager": [true], "upc": ["0329300136012", "0329300135015", "0329300468014", "0329300137019"], "unii": ["W76I6XXF06"]}, "product_type": "Drugs", "event_id": "84836", "recalling_firm": "UNICHEM PHARMACEUTICALS USA INC", "address_1": "1 Tower Center Blvd Ste 2200", "address_2": "N/A", "postal_code": "08816-1145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0829-2020", "product_description": "Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816.  NDC 29300-135-01", "product_quantity": "19161600 units", "reason_for_recall": "Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.", "recall_initiation_date": "20200129", "center_classification_date": "20200206", "termination_date": "20210108", "report_date": "20200212", "code_info": "Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020"}, {"status": "Terminated", "city": "Cranbury", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA078866"], "brand_name": ["BUPROPION HYDROCHLORIDE"], "generic_name": ["BUPROPION HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-736", "47335-737", "47335-738"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUPROPION HYDROCHLORIDE"], "rxcui": ["993503", "993518", "993536"], "spl_id": ["b8e6ae63-c5d7-4481-b7b0-17e135670515"], "spl_set_id": ["29848192-7de3-4c0d-a822-1268dcf128b0"], "package_ndc": ["47335-736-86", "47335-736-88", "47335-736-08", "47335-736-13", "47335-737-86", "47335-737-88", "47335-737-08", "47335-737-13", "47335-738-86", "47335-738-88", "47335-738-08", "47335-738-13"], "is_original_packager": [true], "upc": ["0347335738865", "0347335737868"], "unii": ["ZG7E5POY8O"]}, "product_type": "Drugs", "event_id": "74696", "recalling_firm": "Sun Pharmaceutical Industries, Inc.", "address_1": "270 Prospect Plains Rd", "address_2": "N/A", "postal_code": "08512-3605", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1446-2016", "product_description": "buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc.   Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC  47335-737-86", "product_quantity": "16,085 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20160627", "center_classification_date": "20160720", "termination_date": "20180327", "report_date": "20160727", "code_info": "Lot JKN3477A, exp 07/2016", "more_code_info": ""}, {"status": "Ongoing", "city": "Ta. Kadi, District Mehsana", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M021"], "brand_name": ["MAXIMUM SECURITY"], "generic_name": ["SODIUM FLUORIDE"], "manufacturer_name": ["Bob Barker Company Inc."], "product_ndc": ["53247-132"], "product_type": ["HUMAN OTC DRUG"], "route": ["DENTAL"], "substance_name": ["SODIUM FLUORIDE"], "rxcui": ["245598"], "spl_id": ["067a1e13-c34a-42b0-a16e-a343ff84bf91"], "spl_set_id": ["a89160b6-a204-46c7-8719-bb9c9ed6fe8a"], "package_ndc": ["53247-132-01", "53247-132-02", "53247-132-03", "53247-132-04", "53247-132-05"], "is_original_packager": [true], "unii": ["8ZYQ1474W7"]}, "product_type": "Drugs", "event_id": "96797", "recalling_firm": "KENIL HEALTHCARE PRIVATE LIMITED", "address_1": "Plot 319", "address_2": "Village Acharasan, Ankhol-Vamaj Road", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "DE and NC", "recall_number": "D-0431-2025", "product_description": "Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, Net Wt 0.6 OZ (17 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-02", "product_quantity": "391,680 Tubes", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250424", "center_classification_date": "20250519", "report_date": "20250528", "code_info": "Lot B0009, B0017, Exp Date: 05/31/2026; Lot B0018, B0019, B0036, B0037, B0038, Exp Date: 06/30/2026; Lot B0049, Exp Date: 07/31/2026; B0063, Exp Date: 08/31/2026"}, {"status": "Terminated", "city": "Alpharetta", "state": "GA", "country": "United States", "classification": "Class I", "openfda": {"brand_name": ["NP THYROID 15"], "generic_name": ["LEVOTHYROXINE, LIOTHYRONINE"], "manufacturer_name": ["Acella Pharmaceuticals, LLC"], "product_ndc": ["42192-327"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE", "LIOTHYRONINE"], "rxcui": ["314267", "1855086"], "spl_id": ["f1e67a65-5380-42f8-896d-1d0eda52f6a4"], "spl_set_id": ["a3ff93ad-86ed-4324-ae86-7e7ed3a49db8"], "package_ndc": ["42192-327-01", "42192-327-30"], "is_original_packager": [true], "upc": ["0342192327016"], "nui": ["N0000175945", "M0021504", "N0000175946", "M0021977"], "pharm_class_epc": ["l-Thyroxine [EPC]", "l-Triiodothyronine [EPC]"], "pharm_class_cs": ["Thyroxine [CS]", "Triiodothyronine [CS]"], "unii": ["Q51BO43MG4", "06LU7C9H1V"]}, "product_type": "Drugs", "event_id": "86467", "recalling_firm": "Acella Pharmaceuticals, LLC", "address_1": "1880 Mcfarland Pkwy Ste 110-B", "address_2": "N/A", "postal_code": "30005", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0035-2021", "product_description": "NP Thyroid 15,Thyroid Tablets, USP 1/4 grain (15 mg) 100-count bottles, Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 30005, NDC 42192-327-01", "product_quantity": "19,296 bottles", "reason_for_recall": "Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.", "recall_initiation_date": "20200917", "center_classification_date": "20201019", "termination_date": "20221208", "report_date": "20201028", "code_info": "Lot #: M327E19-1 Exp. 10/2020"}, {"status": "Ongoing", "city": "Denver", "state": "CO", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "97779", "recalling_firm": "STAQ Pharma, Inc.", "address_1": "14135 E 42nd Ave Ste 50", "address_2": "", "postal_code": "80239-5214", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0024-2026", "product_description": "Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.", "product_quantity": "", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date", "recall_initiation_date": "20251009", "center_classification_date": "20251015", "report_date": "20251022", "code_info": "Lot #: 25156673A, Expiry: 02FEB2026.", "more_code_info": ""}, {"status": "Terminated", "city": "Gardena", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84799", "recalling_firm": "Spectrum Laboratory Products", "address_1": "14422 S San Pedro St", "address_2": "N/A", "postal_code": "90248-2027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The recalled API was distributed to pharmacies in the following states: AZ, CA, FL, GA, NJ, PA, RI, SC, TX, UT, WY. The API was also distributed internationally to Canada and UAE.", "recall_number": "D-0825-2020", "product_description": "Ranitidine Hydrochloride (powder), USP, Rx only, Spectrum Chemical Mfg Corp., a) 1 gram, b) 5 grams, c) 25 grams, d)100 grams, e) 500 grams, f) 1 Kilogram", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.", "recall_initiation_date": "20200114", "center_classification_date": "20200204", "termination_date": "20231205", "report_date": "20200212", "code_info": "Lot #:11E0585, Exp. October 2023"}, {"status": "Ongoing", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210921"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-7216"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["POTASSIUM CHLORIDE"], "spl_id": ["9d5dc98f-9e9a-4303-8f20-446e84da3fcf"], "spl_set_id": ["a9d68a40-75e3-4c5c-b5d7-1d6160527fa7"], "package_ndc": ["0904-7216-61"], "original_packager_product_ndc": ["65862-987"], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "96201", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0221-2025", "product_description": "Potassium Chloride Extended-Release Tablets, USP, 10 mEq (750 mg), 100 Tablets per carton (10 x 10 unit dose blisters), Rx Only, Distributed by: Aurobindo Pharma USA< INC., 279 Princeton-Hightstown Road, East Windsor, NJ 08520.  Made in India.  Distributed by: MAJOR PHARMACEUTICALS, Livonia, MI 48152.  NDC: 0904-7216-61", "product_quantity": "6997 cartons", "reason_for_recall": "Failed Dissolution Specifications.", "recall_initiation_date": "20250130", "center_classification_date": "20250204", "report_date": "20250212", "code_info": "Lot# T05224; Exp. 02/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Woburn", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74822", "recalling_firm": "Safecor Health, LLC", "address_1": "317 New Boston St", "address_2": "N/A", "postal_code": "01801-6231", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MA and NY", "recall_number": "D-0900-2017", "product_description": "Acetaminophen 325mg tablets, 120-count bottles, Pk By Safecor Health Woburn, MA 01801, NDC 00904198280.", "product_quantity": "66 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20160707", "center_classification_date": "20170612", "termination_date": "20170712", "report_date": "20170621", "code_info": "Lot #: A18688, Exp. 09/30/2018"}, {"country": "United States", "city": "Earth City", "address_1": "13600 Shoreline Dr", "reason_for_recall": "Failed Dissolution Specification; at the 6-month stability time point", "address_2": "", "product_quantity": "94,584 cartons", "code_info": "Lot A369286, exp. date 31 Jan 2016", "center_classification_date": "20141017", "distribution_pattern": "Nationwide including Puerto Rico.", "state": "MO", "product_description": "Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/carton, and 12 bottles/trays, Professional Sample, Rx only, Forest Pharmaceuticals, Inc., St. Louis, MO. ---  NDC 0456-1420-07", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Forest Pharmaceuticals Inc", "recall_number": "D-0036-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "69298", "termination_date": "20170329", "more_code_info": "", "recall_initiation_date": "20140926", "postal_code": "63045-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0189-2023", "product_description": "Minoxidil 0.75% (1.5ML vial) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221011@36", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90202", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-1138-2022", "product_description": "Syphilinum, Potency: 9C, 30C, 200C, 10X, 12X, Liquid Pellets, Rx only,  Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "15 glass amber bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220513", "center_classification_date": "20220610", "termination_date": "20230525", "report_date": "20220622", "code_info": "Lot# 20390, 20441, 20389", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03022015@2, 5/31/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Fentanyl 1,000 mcg/ml Intrathecal Solution, Sterile-Preservative Free,The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1489-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1035-2015", "product_description": "Nadolol 10 mg/1 mL Susp, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "67462", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21st", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1187-2014", "product_description": "Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml,  20 mL (when reconstituted), Rx only, Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India,  NDC 27437-207-03.", "product_quantity": "5,172 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.", "recall_initiation_date": "20140127", "center_classification_date": "20140402", "termination_date": "20150512", "report_date": "20140409", "code_info": "Lot #s: F300736 Exp. February 2015, F300740 Exp. February 2015, F300741 Exp. February 2015"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077321"], "brand_name": ["LISINOPRIL"], "generic_name": ["LISINOPRIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-512", "68180-513", "68180-517", "68180-980", "68180-981", "68180-982", "68180-979", "68180-514", "68180-515", "68180-516"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISINOPRIL"], "rxcui": ["197884", "205326", "311353", "311354", "314076", "314077"], "spl_id": ["6723a96d-02f8-40c2-95ec-89a7053a7117"], "spl_set_id": ["7d6c31e2-b5a4-4279-8013-a8dad37ea73b"], "package_ndc": ["68180-512-02", "68180-512-30", "68180-512-09", "68180-512-01", "68180-512-03", "68180-513-30", "68180-513-03", "68180-513-01", "68180-513-09", "68180-513-02", "68180-513-05", "68180-517-03", "68180-517-01", "68180-517-30", "68180-517-09", "68180-517-04", "68180-517-02", "68180-980-03", "68180-980-30", "68180-980-01", "68180-980-09", "68180-980-05", "68180-980-02", "68180-981-01", "68180-981-03", "68180-981-30", "68180-981-09", "68180-981-02", "68180-981-05", "68180-982-01", "68180-982-02", "68180-982-30", "68180-982-03", "68180-982-09", "68180-979-01", "68180-979-03", "68180-979-30", "68180-979-09", "68180-514-01", "68180-514-02", "68180-514-03", "68180-514-09", "68180-514-30", "68180-514-05", "68180-515-01", "68180-515-02", "68180-515-03", "68180-515-09", "68180-515-30", "68180-515-05", "68180-516-01", "68180-516-02", "68180-516-03", "68180-516-09", "68180-516-30"], "is_original_packager": [true], "upc": ["0368180513018", "0368180512028", "0368180513032"], "unii": ["E7199S1YWR"]}, "product_type": "Drugs", "event_id": "74945", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "All product distributed domestically in the US. No recalled product was distributed to U.S. Government Agency consignees directly by Lupin.  No recalled product was distributed to any foreign consignees by Lupin.", "recall_number": "D-1503-2016", "product_description": "Lisinopril Tablets USP, 40 mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD  21202, United States; Manufactured by: Lupin Limited, Pithampur (M.P.) 454 775, INDIA, NDC 68180-517-03.", "product_quantity": "5,880 bottles", "reason_for_recall": "CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.", "recall_initiation_date": "20160406", "center_classification_date": "20160916", "termination_date": "20170807", "report_date": "20160928", "code_info": "Batch number: H303449, Exp 09/16", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90211", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0953-2022", "product_description": "Epinephrine Injection, USP, 1 mg/10 mL (100 mcg/mL), 10 mL Pre-Filled Syringe, 5 x 10 mL Pre-Filled Syringes, 6 x 5 Syringe Carton, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-925-10", "product_quantity": "134415 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220518", "center_classification_date": "20220527", "termination_date": "20240823", "report_date": "20220608", "code_info": "Lots: EN1047A, Exp. 6/7/2022; EN2002A, Exp. 7/7/2022; EN2006A, Exp. 7/19/2022; EN2011A, Exp. 9/1/2022"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065095"], "brand_name": ["DOXYCYCLINE HYCLATE"], "generic_name": ["DOXYCYCLINE HYCLATE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-2112"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE HYCLATE"], "rxcui": ["1650143"], "spl_id": ["d3f0f038-6c53-4f67-8397-c6d0ef71a60b"], "spl_set_id": ["9b52e0a7-f024-4d8a-a59e-374946e60b44"], "package_ndc": ["0143-2112-50", "0143-2112-05", "0143-2112-20"], "is_original_packager": [true], "upc": ["0301432112508"], "unii": ["19XTS3T51U"]}, "product_type": "Drugs", "event_id": "80364", "recalling_firm": "West-Ward Columbus Inc", "address_1": "1809 Wilson Rd", "address_2": "N/A", "postal_code": "43228-9579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1024-2018", "product_description": "Doxycycline Hyclate Tablets, USP, 100 mg*. 50-count bottle, Rx only. Manufactured by: West-Ward Pharmaceuticals Corp. Eatontown, NJ 07724. NDC# 0143-2112-50.", "product_quantity": "29,048 bottles (1,452,400 tablets)", "reason_for_recall": "Failed Dissolution Specifications:", "recall_initiation_date": "20180724", "center_classification_date": "20180802", "termination_date": "20200429", "report_date": "20180808", "code_info": "Lot# 71545B, Expiry date: 01/19"}, {"status": "Terminated", "city": "Brooksville", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64188", "recalling_firm": "TG United, Inc.", "address_1": "16275 Aviation Loop Dr", "address_2": "N/A", "postal_code": "34604-6805", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, MS, SC, LA  and TX", "recall_number": "D-515-2013", "product_description": "ED A-HIST TABLETS,  Antihistamine, Nasal Decongestant, 100 count bottle, OTC, Manufactured for: Edwards Pharmaceuticals Inc., Ripley, MS 38663, NDC 0485-0154-01", "product_quantity": "242,470", "reason_for_recall": "CGMP Deviations: Products are underdosed or have an incorrect dosage regime.", "recall_initiation_date": "20130130", "center_classification_date": "20130604", "termination_date": "20160930", "report_date": "20130612", "code_info": "Lot# 11L008 Exp. 10/13; Lot# 12A001 Exp. 12/13; Lot# 12A002  Exp. 12/13; Lot# 12A006  Exp. 12/13; Lot#12A006 Exp. 12/13; Lot# 12A007  Exp. 12/13; Lot#12D013 Exp. 03/14; Lot# 12F002 Exp. 05/14; Lot# 12H006 Exp.07/14;  Lot# 12J001 Exp. 08/14; Lot# 12J001 Exp. 08/14; Lot# 12K005 Exp. 09/14; Lot #12M002 Exp. 11/14; Lot# 12M003 Exp. 11/14."}, {"status": "Terminated", "city": "Qinhuangdao", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "76890", "recalling_firm": "Qinhuangdao Zizhu Pharmaceutical, Co.", "address_1": "No 10, Longhai Road", "address_2": "Economic &amp; Technological Development Zon", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product distributed to NY, TX, SC, CO, MN and NJ", "recall_number": "D-0654-2017", "product_description": "Estradiol Micronized Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd, Qinhuangdao 066004, China (NDC 44132-001-01) (44132-001-06)", "product_quantity": "N/A", "reason_for_recall": "cGMP Deviations; lack of quality assurance.", "recall_initiation_date": "20170324", "center_classification_date": "20170411", "termination_date": "20180703", "report_date": "20170419", "code_info": "Batch 80001512002 to Batch 80801604003, exp 10/22/2017 through 3/30/3018", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "1 Bag", "code_info": "Compounded on 05/27/15, Discard After: 06/24/15", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "HYDROmorphone HCl PF, HYDROMORPHONE HCL 1000mg  /NS 500mL,  Qty: 1 500 mL Bag, Rx Only.  Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1178-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0481-2020", "product_description": "OCuSOFT retaine NaCl Ophthalmic Ointment, Product Size: 3.5g,  SKU #: 777-3-76", "product_quantity": "19632 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "Lot #: SAP     1/20     3/16/2018       SFI     6/20     10/29/2018       TCI     3/21"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "10 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 35/2.5 mg/1 mcg/mL,  10 mL, unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0712-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86343", "recalling_firm": "RLC Labs Inc.", "address_1": "1850 E Riverview Dr", "address_2": "N/A", "postal_code": "85034-6703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the United States", "recall_number": "D-1613-2020", "product_description": "WP Thyroid, Westhroid Pure, 2 Grain (130 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-5950-2 ; b) 30 Tablets, NDC 64727-5950-4; c) 60 Tablets, NDC 64727-5950-5; d) 90 Tablets, NDC 64727-5950-6; e) 100 Tablets, NDC 64727-5950-1; Rx Only, Manufactured by: RLC Labs Phoenix, AZ 85034", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: manufactured under the same conditions as those found to be subpotent.", "recall_initiation_date": "20200825", "center_classification_date": "20200924", "termination_date": "20231108", "report_date": "20200923", "code_info": "All lots with expiry between 10/2020-07/2023"}, {"country": "United States", "city": "Ridgefield", "address_1": "900 Ridgebury Rd", "reason_for_recall": "Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and  50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.", "address_2": "", "product_quantity": "2562 bottles", "code_info": "Lot #:456520, Exp.  5/17", "center_classification_date": "20161024", "distribution_pattern": "Nationwide", "state": "CT", "product_description": "Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT  06877, NDC 0597-0019-01", "report_date": "20161102", "classification": "Class II", "openfda": {}, "recalling_firm": "Boehringer Ingelheim Pharmaceuticals, Inc.", "recall_number": "D-0113-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "75374", "termination_date": "20171129", "more_code_info": "", "recall_initiation_date": "20161006", "postal_code": "06877-1058", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hendersonville", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83997", "recalling_firm": "Basic Reset Inc.", "address_1": "260 W Main St Ste 103", "address_2": "N/A", "postal_code": "37075-7316", "voluntary_mandated": "FDA Mandated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and U.S. Virgin Islands, Canada, Nigeria, United Kingdom, Australia, Israel, Hungary, UAE, Mexico, Philippines, Greece", "recall_number": "D-0189-2020", "product_description": "Basic Reset Nuovi Skin Toner, Refined Ionyte, 4 FL. OZ., 118.3 mL bottle, Distributed by: Basic Reset Hendersonville, TN 37075", "product_quantity": "1000 bottles", "reason_for_recall": "Marketed without an Approved NDA/ANDA", "recall_initiation_date": "20191018", "center_classification_date": "20191105", "termination_date": "20211027", "report_date": "20191113", "code_info": "Lots: 28917A, 23918A, 21519A"}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1500", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Fentanyl Citrate 50 mcg/mL, 5ml syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC 45183-0964-70", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1337-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Concord", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75141", "recalling_firm": "Mckesson Packaging Services", "address_1": "7101 Weddington Rd NW", "address_2": "N/A", "postal_code": "28027-3412", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1550-2016", "product_description": "Lansoprazole Delayed-Release Capsules, USP, 30 mg, packaged in 100-count cartons of 10 x 10 unit dose blister cards, Rx only, Manufactured by: Dr. Reddy's Laboratories, Inc., 200 Somerset Corporate Blvd Floor 7, Bridgewater, NJ 08807, NDC 63739-0555-10", "product_quantity": "181 unit cartons of 10 x 10 blister cards", "reason_for_recall": "Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.", "recall_initiation_date": "20160908", "center_classification_date": "20160928", "termination_date": "20170503", "report_date": "20161005", "code_info": "Lot # 0111295, Exp 9/17"}, {"status": "Terminated", "city": "West Palm Beach", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95219", "recalling_firm": "Elevate Oral Care", "address_1": "342 Pike Rd Ste 23", "address_2": "", "postal_code": "33411-3820", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "120 direct customers, Nationwide US. No foreign, DOD/VA.", "recall_number": "D-0658-2024", "product_description": "Just Right 5000, 1.1% Sodium Fluoride, Candy Apple Flavor, Net Wt. 3.4oz (97g), Rx Only, Manufactured for Elevate Oral Care, LLC in the U.S.A with imported pump, 346 Pike Rd, Suite 5, West Palm Beach, FL 33411, NDC 57511-002-1", "product_quantity": "", "reason_for_recall": "LABELING: LABEL MIX-UP.", "recall_initiation_date": "20240820", "center_classification_date": "20240912", "termination_date": "20250805", "report_date": "20240918", "code_info": "Lot #G073DC, Exp 3/31/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0811-2019", "product_description": "Dr. King's SafeCare Rx Allergies Northest U.S., 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955260721, NDC 57955-2707-2", "product_quantity": "842 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 051716G Exp. 05/19; 072516H Exp. 07/19; 081117C Exp. 08/19"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0740-2023", "product_description": "oxyTOCIN 40 units added to 0.9% sodium chloride 1,000 bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-8069-1.", "product_quantity": "2186 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-886265, Exp 05/11/2023; 37-886266, Exp 05/11/2023; 37-889903, Exp 05/25/2023; 37-890551, Exp 05/29/2023; 37-892521, 37-892620, Exp 06/06/2023; 37-896246, 37-896247, Exp 06/20/2023; 37-898553, Exp 06/29/2023"}, {"country": "United States", "city": "New Hyde Park", "address_1": "1111 Marcus Ave", "reason_for_recall": "Incorrect Product Formulation: wrong sunscreen product in the package.", "address_2": "", "product_quantity": "47,128 tubes", "code_info": "Lot Codes: a) 7363B, 7363I, 8002C, 8002I, 8054J, 8055B, 8174A; and b) 7353", "center_classification_date": "20180713", "distribution_pattern": "Nationwide in the USA", "state": "NY", "product_description": "alba BOTANICA sport mineral sunscreen (titanium dioxide 7.0% and zinc oxide 9.0%), spf 45, 170 g (6 oz) tubes packaged in a) 4 tubes per case; b) 8 pack shipper display; Manufactured By: The Hain Celestial Group, Inc., Lake Success, NY  11042, UPC 7 24742 01102 4.", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "The Hain Celestial Group, Inc. - Worldwide HQ", "recall_number": "D-0920-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80473", "termination_date": "20181128", "more_code_info": "", "recall_initiation_date": "20180705", "postal_code": "11042-1221", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212399"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-447", "16729-458", "16729-448", "16729-449", "16729-451", "16729-450", "16729-452", "16729-453", "16729-454", "16729-455", "16729-456", "16729-457"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["415fc774-31a5-124f-e063-6294a90a0e46"], "spl_set_id": ["a6233381-3043-4e9a-aaa6-a6b105e5142b"], "package_ndc": ["16729-458-15", "16729-458-17", "16729-447-15", "16729-447-17", "16729-448-15", "16729-448-17", "16729-449-15", "16729-449-17", "16729-451-15", "16729-451-17", "16729-450-15", "16729-450-17", "16729-452-15", "16729-452-17", "16729-453-15", "16729-453-17", "16729-454-15", "16729-454-17", "16729-455-15", "16729-455-17", "16729-456-15", "16729-456-17", "16729-457-15", "16729-457-17"], "is_original_packager": [true], "upc": ["0316729447157", "0316729449151", "0316729452151", "0316729454155", "0316729453158", "0316729448154", "0316729451154", "0316729457156", "0316729450157", "0316729456159", "0316729458153", "0316729455152"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "95747", "recalling_firm": "ACCORD HEALTHCARE, INC.", "address_1": "8041 Arco Corporate Dr Ste 200", "address_2": "", "postal_code": "27617-2010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0076-2025", "product_description": "Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-449-17", "product_quantity": "", "reason_for_recall": "Subpotent drug", "recall_initiation_date": "20241108", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: D2300191, Exp 12/31/2025", "more_code_info": ""}, {"country": "United States", "city": "Little Rock", "address_1": "7321 Cantrell Rd", "reason_for_recall": "Lack of Assurance of Sterility - the firm is recalling select sterile drug products.", "address_2": "", "product_quantity": "73 bags", "code_info": "Lot: 168032", "center_classification_date": "20161213", "distribution_pattern": "Nationwide", "state": "AR", "product_description": "Calcium Chloride (20 mg/mL) in 0.9% Sodium Chloride 500 mL Bag, Rx Only, Single-Dose Bag Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207,  NDC 52533-102-09", "report_date": "20161221", "classification": "Class II", "openfda": {}, "recalling_firm": "Cantrell Drug Company", "recall_number": "D-0186-2017", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "75745", "termination_date": "20200429", "more_code_info": "", "recall_initiation_date": "20161118", "postal_code": "72207-4144", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "62 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 30/1 mg/10 mcg/mL;  5 mL, 7 mL and 10 mL unit sizes, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0705-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]